4 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 30.1% per year over the past 3 years.
Net income has grown slower than revenue (8.4% vs 30.1% per year).
Operating margin has contracted, at 5.9% in the latest year.
Financial health
Total debt ($353M) exceeds cash ($197M); net debt is $156M.
Total debt has grown in line with revenue (28.9% vs 30.1% per year).
Operating income covered interest expense 11× in the latest year, up from 9.0× 3 years ago.
Total debt is 1.1× EBITDA.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$5.3B
$192M
0.0%
5.9%
—
$353M
$197M
2024
$4.1B
$56M
0.0%
3.0%
—
$412M
$158M
2023
$3.1B
$113M
0.0%
6.7%
—
$213M
$73M
2022
$2.4B
$150M
0.0%
9.6%
—
—
$58M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$1.4B
$81M
0.0%
8.5%
—
$248M
$248M
Dec '25
$1.4B
$60M
0.0%
7.0%
—
$353M
$197M
Sep '25
$1.3B
$52M
0.0%
6.4%
—
$253M
$356M
Jun '25
$1.3B
$51M
0.0%
6.2%
—
$257M
$294M
Mar '25
$1.3B
$28M
0.0%
3.8%
—
$262M
$288M
Dec '24
$1.2B
$37M
0.0%
6.0%
—
$412M
$158M
Sep '24
$1.0B
$16M
17.1%
2.2%
—
$269M
$50M
Jun '24
$935M
-$32M
18.5%
-4.0%
—
$243M
$73M
Mar '24
$919M
$35M
19.9%
7.1%
—
$248M
$81M
Dec '23
$853M
$34M
0.0%
7.3%
—
$213M
$73M
Sep '23
$789M
$20M
19.1%
4.6%
—
—
$69M
Jun '23
$760M
$21M
22.3%
6.5%
—
—
$38M
Mar '23
$708M
$38M
23.9%
8.4%
—
—
$94M
Valuation over time
How the market has priced PACS against its own fundamentals since 2024-04 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 34.9× (Apr '24) to 33.6× (Jun '26).
The price-to-sales ratio has fallen from 1.3× (Apr '24) to 1.2× (Jun '26).
The dividend yield has fallen from 2.0% (Apr '24) to 0.6% (Nov '25).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is PACS growing its revenue and profit?
Over the past 3 years, Pacs Group, Inc.'s revenue has grown 30.1% per year, and net income grown 8.4% per year. These are computed facts, not advice.
How much debt does PACS have?
As of FY2025, Pacs Group, Inc. reported $353M of total debt against $197M of cash; operating income covered interest expense 11×.
What is PACS's profit margin?
In FY2025, gross margin was —, operating margin 5.9%, and net margin 3.6%.
What is PACS's P/E ratio?
As of Jun '26, Pacs Group, Inc. traded at a price-to-earnings ratio of about 33.6× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.